VOLZ, H. P., Eliška BARTEČKŮ, Lucie BARTOVA, J. BESSA, D. DE BERARDIS, J. DRAGASEK, H. KOZHUHAROV, M. LADEA, J. LAZÁRY, M. ROCA, G. USOV, A. WICHNIAK, B. GODMAN and S. KASPER. Sick leave duration as a potential marker of functionality and disease severity in depression. International Journal of Psychiatry in Clinical Practice. Oxon: TAYLOR & FRANCIS LTD, 2022, vol. 26, No 4, p. 406-416. ISSN 1365-1501. Available from: https://dx.doi.org/10.1080/13651501.2022.2054350.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Sick leave duration as a potential marker of functionality and disease severity in depression
Authors VOLZ, H. P. (guarantor), Eliška BARTEČKŮ (203 Czech Republic, belonging to the institution), Lucie BARTOVA (203 Czech Republic), J. BESSA, D. DE BERARDIS, J. DRAGASEK, H. KOZHUHAROV, M. LADEA, J. LAZÁRY, M. ROCA, G. USOV, A. WICHNIAK, B. GODMAN and S. KASPER.
Edition International Journal of Psychiatry in Clinical Practice, Oxon, TAYLOR & FRANCIS LTD, 2022, 1365-1501.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30215 Psychiatry
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.000
RIV identification code RIV/00216224:14110/22:00126851
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1080/13651501.2022.2054350
UT WoS 000777522800001
Keywords in English Absenteeism; depression; functionality; major depressive disorder; return to work; sick leave
Tags 14110222, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 16/1/2023 13:57.
Abstract
Objective: To discuss the impact of depression on work and how depression-related sick leave duration could be a potential indicator and outcome for measuring functionality in depression. Methods: Our review was based on a literature search and expert opinion that emerged during a virtual meeting of European psychiatrists that was convened to discuss this topic. Results: Current evidence demonstrates that depression-related sick leave duration is influenced by multiple disease-, patient- and work-related factors, together with societal attitudes towards depression and socioeconomic conditions. A wide variety of pharmacological and non-pharmacological treatments and work-based interventions are effective in reducing depression-related sick leave duration and/or facilitating return to work. Recent real-world evidence showed that patients treated with antidepressant monotherapy appear to recover their working life faster than those receiving combination therapy. Although depression-related sick leave duration was found to correlate with severity of depressive symptoms, it cannot be used alone as a viable marker for disease severity. Conclusions: Given its multifactorial nature, depression-related sick leave duration is not on its own a viable outcome measure of depression severity but could be used as a secondary outcome alongside more formal severity measures and may also represent a useful measure of functionality in depression.
PrintDisplayed: 24/6/2024 23:20